| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP CLO & General Counsel | EVP Legal & General Counsel | EVP & General Counsel +3 more
1 company
Patrick R. O'Neil is EVP CLO & General Counsel at IONS. From January 2019 to August 2026, the filings on record show 0 open-market purchases and 31 sales. Patrick R. O'Neil's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $2.4M at current prices.
Historically, Patrick R. O'Neil's trades have earned a middling insider score of 63/100 across 26 rated trades. Over a 12-month horizon, 59.1% of those trades were profitable, with an average 12-month return of -9.2%.
The IONS filings lean toward selling, a net 463,394 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2023 | IONS Ionis Pharmaceuticals Inc | EVP CLO & General Counsel | Sell | 9,000 | $39.56 | $356,071.95 | -18.5% | -10.5% | +28.9% | |
| Jan 18, 2023 | IONS Ionis Pharmaceuticals Inc | EVP CLO & General Counsel | Sale+OE | 7,836 | $39.49 | $309,479.69 | -13.9% | -8.6% | +27.2% | |
| Apr 12, 2022 | IONS Ionis Pharmaceuticals Inc | EVP CLO & General Counsel | Sell | 6,792 | $40.06 | $272,056.96 | -16.4% | -7.8% | -7.7% | |
| Jan 25, 2021 | IONS Ionis Pharmaceuticals Inc | EVP & General Counsel | Sell | 5,324 | $63.50 | $338,074.00 | -16.7% | - | - | |
| Feb 10, 2020 | IONS Ionis Pharmaceuticals Inc | SVP & General Counsel | Sell | 3,882 | $59.60 | $231,367.20 | -15.8% | - | - | |
| Apr 5, 2019 | IONS Ionis Pharmaceuticals Inc | SVP Legal & General Counsel | Sale+OE | 49,528 | $83.99 | $4,160,075.12 | -74.8% | - | - | |
| Mar 18, 2019 | IONS Ionis Pharmaceuticals Inc | SVP Legal & General Counsel | Sale+OE | 28,800 | $78.79 | $2,269,186.56 | -59.4% | - | - | |
| Feb 27, 2019 | IONS Ionis Pharmaceuticals Inc | SVP Legal & General Counsel | Sale+OE | 26,800 | $68.01 | $1,822,579.52 | -57.7% | - | - | |
| Feb 12, 2019 | IONS Ionis Pharmaceuticals Inc | SVP Legal & General Counsel | Sale+OE | 275 | $59.50 | $16,362.50 | -1.4% | - | - | |
| Feb 5, 2019 | IONS Ionis Pharmaceuticals Inc | SVP Legal & General Counsel | Sale+OE | 19,600 | $59.25 | $1,161,360.00 | -49.9% | - | - |